digestive/alimentary system
• mice develop multiple polyps in the small intestine one month after completion of pIpC injection to induce Cre expression
• polyps show a large excess of crypt-like units at their base and aberrant positioning of crypts along the edges of villi
• overgrowth and insertions of stromal cells from the base of the polypoid mass are seen in the small intestine one month after completion of pIpC injection to induce Cre expression
• intestinal stem cells exhibit increased proliferation due to Akt activation and nuclear localization of beta-catenin resulting in an increase of intestinal stem cells in the crypts
• these excess stem cells initiate de novo crypt formation and crypt fission at a higher rate than in controls
|
neoplasm
• mice injected with pIpC to induce Pten deletion, develop myeloproliferative disease and T-cell acute lymphoblastic leukemia
|
immune system
• mice injected with pIpC to induce Pten deletion have an enlarged thymus
|
• mice injected with pIpC to induce Pten deletion have an enlarged spleen
|
mortality/aging
• mean survival time of mice injected with pIpC to induce Pten deletion is 35 days
|
hematopoietic system
• mice injected with pIpC to induce Pten deletion have an enlarged thymus
|
• mice injected with pIpC to induce Pten deletion have an enlarged spleen
|
endocrine/exocrine glands
• mice injected with pIpC to induce Pten deletion have an enlarged thymus
|
growth/size/body
• mice injected with pIpC to induce Pten deletion have an enlarged spleen
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
acute lymphoblastic leukemia | DOID:9952 |
OMIM:247640 OMIM:613065 |
J:169097 | |
Cowden syndrome | DOID:6457 |
OMIM:PS158350 |
J:118329 |